April 7, 2005: Pfizer Voluntarily Withdraws Bextra
It was on April 7, 2004, when the US Food and Drug Administration or US FDA declared that it requested Pfizer to voluntarily recall the product Bextra (valdecoxib) from the entire US market. Pfizer agreed to stop the sales and marketing of Bextra in the US, pending deliberations with the FDA.